Caitlin Cronin
Stock Analyst at Canaccord Genuity
(4.18)
# 465
Out of 5,097 analysts
46
Total ratings
55.88%
Success rate
15.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENOV Enovis | Maintains: Buy | $58 → $50 | $27.20 | +83.82% | 4 | Dec 17, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.43 | +3.95% | 6 | Dec 17, 2025 | |
| GMED Globus Medical | Maintains: Buy | $90 → $105 | $89.36 | +17.50% | 2 | Dec 17, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $72 → $85 | $76.61 | +10.95% | 3 | Dec 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $27 → $37 | $32.74 | +13.01% | 8 | Dec 5, 2025 | |
| TELA TELA Bio | Maintains: Buy | $7 → $4 | $1.14 | +250.88% | 5 | Nov 18, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $36 → $34 | $33.12 | +2.66% | 4 | Nov 11, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $25 | $20.70 | +20.77% | 5 | Oct 31, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $58 | $37.37 | +55.20% | 4 | Aug 1, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $7.48 | +100.53% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $6.07 | -34.10% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $130 | $89.80 | +44.77% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $2.18 | +450.46% | 1 | Nov 14, 2023 |
Enovis
Dec 17, 2025
Maintains: Buy
Price Target: $58 → $50
Current: $27.20
Upside: +83.82%
InMode
Dec 17, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.43
Upside: +3.95%
Globus Medical
Dec 17, 2025
Maintains: Buy
Price Target: $90 → $105
Current: $89.36
Upside: +17.50%
Establishment Labs Holdings
Dec 17, 2025
Maintains: Buy
Price Target: $72 → $85
Current: $76.61
Upside: +10.95%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $27 → $37
Current: $32.74
Upside: +13.01%
TELA Bio
Nov 18, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $1.14
Upside: +250.88%
Smith & Nephew
Nov 11, 2025
Maintains: Hold
Price Target: $36 → $34
Current: $33.12
Upside: +2.66%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $25
Current: $20.70
Upside: +20.77%
Vericel
Aug 1, 2025
Maintains: Buy
Price Target: $61 → $58
Current: $37.37
Upside: +55.20%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $7.48
Upside: +100.53%
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $6.07
Upside: -34.10%
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $89.80
Upside: +44.77%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $2.18
Upside: +450.46%